Skip to main content

Table 1 Baseline patient demographics (n = 36)

From: Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience

Characteristics Vaginal cancer (n = 16) Vulvar cancer (n = 20)
Median age, years (range) 60 (30 to 85) 55 (33 to 78)
Race, n (%)
White 13 (81 %) 19 (95 %)
Black 1 (6 %) 0
Hispanic 2 (13 %) 0
Asian 0 1 (5 %)
Body Mass Index, n (%)
Underweight (<18.5) 0 1 (5 %)
Normal Weight (18.5 to 25) 10 (62 %) 13 (65 %)
Overweight (>25) 6 (38 %) 6 (30 %)
The Eastern Cooperative Oncology Group Performance Status, n (%)
0 4 (25 %) 0
1 9 (56 %) 18 (90 %)
2 3 (19 %) 2 (10 %)
Prior Chemotherapy
Yes, n (%) 14 (88 %) 16 (80 %)
Median number (range) 2 (0 to 4) 1 (0 to 6)
Prior Radiation Therapy   
Yes, n (%) 15 (94 %) 17 (85 %)
Pathological Diagnosis, n (%)
Squamous Cell Carcinoma 7 (44 %) 17 (85 %)
Adenocarcinoma 4 (25 %) 0
Melanoma 3 (19 %) 3 (15 %)
Carcinosarcoma 1 (6 %) 0
High-grade neuroendocrine carcinoma 1 (6 %) 0
Phase I Trial Enrollment, n (%) 11 (69 %) 16 (80 %)